v1.1: full gene space + specificity z-score; hydroxyurea recovers

Post-hoc improvement after the pre-registered v1 recovery test failed.
Two changes, diagnosing v1's failure:
- score on the full 12,328-gene LINCS space (week2_lincs_extract.py),
  lifting signature overlap from 12% to 85% (brings erythroid markers in)
- src/scoring.py: KS connectivity + per-drug specificity z-score
  (spec_z = SDs below a 1,000 random-query null). Primary ranking is
  now spec_z. (Textbook tau saturated at +/-100 for a coherent query —
  documented; needs a reference-signature library, a v2 item.)
- week3_scoring.py: spec_z primary + WTCS reference + prior-blended
- tests: tau/spec_z calibration test; 19 passing
- scripts/exp_genespace.py: the BING vs all-12,328 comparison

Result: hydroxyurea recovers (rank 40 -> 18, top 6%, passes top-10%),
confirming the v1 failure was the landmark bottleneck not the algorithm.
Overall STILL FAILS: L-glutamine does not reverse (rank 213, metabolite),
and negative controls (norethindrone, ciprofloxacin) rank top-3 —
connectivity != therapeutic relatedness. v1.1 is post-hoc/exploratory,
not a confirmatory test; reported as such in recovery_test_report.md.

Co-Authored-By: Claude Opus 4.8 (1M context) <noreply@anthropic.com>
This commit is contained in:
2026-06-23 22:57:30 +02:00
parent 72f1a49de6
commit 3417f85eb1
9 changed files with 378 additions and 150 deletions

View File

@@ -61,9 +61,10 @@ Reproduce with `scripts/week1_explore.py` (download + DE + concordance) then
38%, as expected). 43 drugs carry target annotations; 46 carry mechanism-of-action.
- **Tier:** all signature-backed drugs are Tier B (LINCS is a single source → fails Tier A's
not-single-source rule).
- **Signature↔landmark overlap:** only 56/477 (12%) of the disease signature genes are LINCS
landmarks, so connectivity scoring (Week 3) uses a 30-up/26-down query. The erythroid hallmark
genes (CA1, AHSP, SLC4A1, HBG) are NOT landmarks. This is a key limitation for the recovery test.
- **Gene space (v1.1):** scoring uses the full **12,328-gene** LINCS space, not just the 978
landmarks. Signature overlap is 406/477 (85%) vs 56/477 (12%) for landmark-only — the larger
space is what recovers hydroxyurea (see recovery_test_report.md). HBG1/HBG2 are absent from
LINCS entirely and remain unscoreable.
- Reproduce: `week2_curate_drugset.py``week2_chembl.py` → download Level-5 GCTX →
`week2_lincs_extract.py``week2_assemble.py`.